Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1021-1030 of 1,298) with videos related to

Pageof 130
Sort By:
Scientific Reports|September 2, 2017
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancerSiv Mjos, Henrica M J Werner, Even Birkeland, et al.
Cell Reports. Medicine|December 3, 2024
UBA1 inhibition sensitizes cancer cells to PARP inhibitorsSharad Awasthi, Lacey E Dobrolecki, Christina Sallas, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Global mRNA 3'UTR lengthening in small-cell neuroendocrine carcinomaYi Zhang, Xiaofan Zhao, Huan Wang, et al.
Science Translational Medicine|February 5, 2025
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor-resistant <i>NRAS</i>-mutant melanomaBrittany Lipchick, Adam N Guterres, Hsin-Yi Chen, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
Innovation (Cambridge (Mass.))|January 3, 2022
Profiling of immune features to predict immunotherapy efficacyYouqiong Ye, Yongchang Zhang, Nong Yang, et al.
Cancer Discovery|October 11, 2011
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stabilityLydia W T Cheung, Bryan T Hennessy, Jie Li, et al.
Cancer Research|February 18, 2011
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimersRitwik Ghosh, Archana Narasanna, Shizhen Emily Wang, et al.
Nature|January 31, 2020
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesisKwanha Yu, Chia-Ching John Lin, Asante Hatcher, et al.
Pageof 130

Showing results (1021-1030 of 1,298) with videos related to

Sort By:
Pageof 130
Scientific Reports|September 2, 2017
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancerSiv Mjos, Henrica M J Werner, Even Birkeland, et al.
Cell Reports. Medicine|December 3, 2024
UBA1 inhibition sensitizes cancer cells to PARP inhibitorsSharad Awasthi, Lacey E Dobrolecki, Christina Sallas, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Global mRNA 3'UTR lengthening in small-cell neuroendocrine carcinomaYi Zhang, Xiaofan Zhao, Huan Wang, et al.
Science Translational Medicine|February 5, 2025
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor-resistant <i>NRAS</i>-mutant melanomaBrittany Lipchick, Adam N Guterres, Hsin-Yi Chen, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
Innovation (Cambridge (Mass.))|January 3, 2022
Profiling of immune features to predict immunotherapy efficacyYouqiong Ye, Yongchang Zhang, Nong Yang, et al.
Cancer Discovery|October 11, 2011
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stabilityLydia W T Cheung, Bryan T Hennessy, Jie Li, et al.
Cancer Research|February 18, 2011
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimersRitwik Ghosh, Archana Narasanna, Shizhen Emily Wang, et al.
Nature|January 31, 2020
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesisKwanha Yu, Chia-Ching John Lin, Asante Hatcher, et al.
Pageof 130